OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
Bastian Höchst, Frank A. Schildberg, Pia Sauerborn, et al.
Journal of Hepatology (2013) Vol. 59, Iss. 3, pp. 528-535
Closed Access | Times Cited: 129

Showing 1-25 of 129 citing articles:

Advances in immunotherapy for hepatocellular carcinoma
Bruno Sangro, Pablo Sarobe, Sandra Hervás‐Stubbs, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 525-543
Open Access | Times Cited: 926

The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer
Silvia Affò, Le–Xing Yu, Robert F. Schwabe
Annual Review of Pathology Mechanisms of Disease (2016) Vol. 12, Iss. 1, pp. 153-186
Open Access | Times Cited: 552

Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesús Prìeto, Ignacio Melero, Bruno Sangro
Nature Reviews Gastroenterology & Hepatology (2015) Vol. 12, Iss. 12, pp. 681-700
Closed Access | Times Cited: 524

Myeloid‐derived suppressor cell heterogeneity in human cancers
Samantha Solito, Ilaria Marigo, Laura Pinton, et al.
Annals of the New York Academy of Sciences (2014) Vol. 1319, Iss. 1, pp. 47-65
Closed Access | Times Cited: 378

Liver metastases
Diamantis I. Tsilimigras, Pnina Brodt, Pierre–Alain Clavien, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Closed Access | Times Cited: 342

Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets
Yoon Mee Yang, Sohee Kim, Ekihiro Seki
Seminars in Liver Disease (2019) Vol. 39, Iss. 01, pp. 026-042
Open Access | Times Cited: 341

The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Romain Donné, Amaia Lujambio
Hepatology (2022) Vol. 77, Iss. 5, pp. 1773-1796
Closed Access | Times Cited: 319

Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases
Sha Li, Ming Hong, Hor‐Yue Tan, et al.
Oxidative Medicine and Cellular Longevity (2016) Vol. 2016, Iss. 1
Open Access | Times Cited: 317

Immunity, tolerance and autoimmunity in the liver: A comprehensive review
Derek G. Doherty
Journal of Autoimmunity (2015) Vol. 66, pp. 60-75
Closed Access | Times Cited: 268

The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma
Jacopo Baglieri, David A. Brenner, Tatiana Kisseleva
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1723-1723
Open Access | Times Cited: 264

Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
Laura J. Pallett, Upkar S. Gill, Alberto Quaglia, et al.
Nature Medicine (2015) Vol. 21, Iss. 6, pp. 591-600
Open Access | Times Cited: 247

Immune tolerance in liver disease
Ian Nicholas Crispe
Hepatology (2014) Vol. 60, Iss. 6, pp. 2109-2117
Open Access | Times Cited: 246

Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology.
Ralf Weiskirchen, Frank Tacke
PubMed (2014) Vol. 3, Iss. 6, pp. 344-63
Closed Access | Times Cited: 242

MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Yungang Wang, Yanxia Ding, Naizhou Guo, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 232

The significance of intertumor and intratumor heterogeneity in liver cancer
Jinping Liu, Hien Dang, Xin Wei Wang
Experimental & Molecular Medicine (2018) Vol. 50, Iss. 1, pp. e416-e416
Open Access | Times Cited: 201

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
Rachel A. Burga, Mitchell Thorn, Gary R. Point, et al.
Cancer Immunology Immunotherapy (2015) Vol. 64, Iss. 7, pp. 817-829
Open Access | Times Cited: 198

Hepatic Immune Regulation and Its Involvement in Viral Hepatitis Infection
Percy A. Knolle, Robert Thimme
Gastroenterology (2014) Vol. 146, Iss. 5, pp. 1193-1207
Open Access | Times Cited: 194

Regulatory myeloid cells paralyze T cells through cell–cell transfer of the metabolite methylglyoxal
Tobias Baumann, Andreas Dunkel, Christian Schmid, et al.
Nature Immunology (2020) Vol. 21, Iss. 5, pp. 555-566
Closed Access | Times Cited: 188

Immune-based therapies for hepatocellular carcinoma
David J. Pinato, Nadia Guerra, Petros Fessas, et al.
Oncogene (2020) Vol. 39, Iss. 18, pp. 3620-3637
Open Access | Times Cited: 180

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
Chen Chen, Zehua Wang, Yi Ding, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 127

Antioxidative Hyaluronic Acid–Bilirubin Nanomedicine Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy
Jongyoon Shinn, Seojeong Park, Seonju Lee, et al.
ACS Nano (2024) Vol. 18, Iss. 6, pp. 4704-4716
Closed Access | Times Cited: 23

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
Imane Azzaoui, Fabrice Uhel, Delphine Rossille, et al.
Blood (2016) Vol. 128, Iss. 8, pp. 1081-1092
Open Access | Times Cited: 151

The role of innate immunity in the immunopathology and treatment of HBV infection
Mala K. Maini, Adam J. Gehring
Journal of Hepatology (2016) Vol. 64, Iss. 1, pp. S60-S70
Open Access | Times Cited: 148

Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
Man Liu, Jingying Zhou, Xiaoyu Liu, et al.
Gut (2019) Vol. 69, Iss. 2, pp. 365-379
Closed Access | Times Cited: 144

Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma
Juling Ji, Tobias Eggert, Anuradha Budhu, et al.
Hepatology (2015) Vol. 62, Iss. 2, pp. 481-495
Open Access | Times Cited: 139

Page 1 - Next Page

Scroll to top